Dear Investors,

Imagine a world where Alzheimer’s isn’t a life sentence but a treatable condition. NeuroEM is on the verge of making that a reality, and we invite you to be part of this breakthrough.

Join us for a private investor dinner on Thursday, March 27 at 5:30PM ET in Tysons Corner, Virginia, where you’ll gain early access to an opportunity poised to disrupt the $300B Alzheimer’s market.

Why You Should Attend

✔ First-Mover Advantage – Meet NeuroEM’s visionary team and discover how their FDA-designated Breakthrough Device is transforming Alzheimer’s treatment.

✔ A Game-Changing Solution – Backed by 10+ years of university research, 2 NIH grants, and 9 issued patents, this non-invasive device has clinically demonstrated cognitive improvement in Alzheimer’s patients within just two months.

✔ Network with Elite Investors – Connect with top-tier investors, family offices, and industry pioneers in an intimate, high-caliber setting.

The Science Behind NeuroEM

NeuroEM’s TEMT-RF (Transcranial Electro-Magnetic Treatment using Radio Frequencies) has shown remarkable success in clinical trials:

– 7 of 8 Alzheimer’s patients experienced cognitive improvement within just two months.

– Disrupts Alzheimer’s at its core by detoxifying the brain, reducing inflammation, and restoring cellular energy (ATP)—a trifecta never before achieved in Alzheimer’s treatment.

– 10 additional patents pending worldwide, with deep scientific validation from leading institutions and the NIH.

Why This Opportunity is Unique

The Alzheimer’s market is at a tipping point, and NeuroEM is first in line to redefine it.

– Raising $5M Seed Preferred (attractive pre-money valuation: $15M).

– Planned $5-10M Series A in 2025

– 55M+ patients worldwide, with healthcare systems spending 3x more on Alzheimer’s patients.

With the FDA’s Breakthrough Device designation, NeuroEM is positioned as an industry leader—offering a scalable, cost-effective alternative to pharmaceuticals with far superior results.

Event Details – Limited to Select Investors

📍 Location: Tysons Corner, VA (venue will be confirmed upon Registration)

📅 Date: Thursday, March 27, 2025

🕔 Time: 5:30PM ET

⚠️ Exclusive Invite-Only Event – Seats Are Extremely Limited ⚠️

This invitation is extended only to accredited investors, family offices, and investment advisors. RSVP now to secure your place.

For details, or to request the executive summary or investment deck, please contact Skylar Rallison at srallison@opus8.com.

Secure your spot today. Spaces are limited and subject to review. We look forward to welcoming you for an evening of high-impact investing, powerful insights, and the future of Alzheimer’s treatment.

Best regards,

Tien Wong

CEO

Opus8, Inc.